Clinical Trials for Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma

Find clinical trials for refractory t-cell/histiocyte-rich large b-cell lymphoma. Discover research opportunities and treatment options in your area.

4 Active Trials Found

Showing 4 trials on this page

Page 1 of 1

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

NCT ID: NCT06649812

This clinical trial, called ViPOR, is exploring a new combination of treatments for patients with aggressive types of B-cell lymphoma that have either come back after treatment (relapsed) or have n...

Not yet recruiting

Phase: PHASE2 Type: interventional

Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy

NCT ID: NCT06834373

This clinical trial is looking at a new treatment approach for patients with aggressive types of B-cell non-Hodgkin lymphoma that have either come back after treatment (relapsed) or did not respond...

Recruiting

Phase: PHASE2 Type: interventional Locations: Scottsdale, Arizona, United States, Jacksonville, Florida, United States +5 more

TTI-622 in Combination With Pembrolizumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma

NCT ID: NCT05507541

This clinical trial is exploring a new treatment option for patients with a type of blood cancer called diffuse large B-cell lymphoma, which has either returned after treatment or has not responded...

Recruiting

Phase: PHASE2 Type: interventional Locations: Rochester, Minnesota, United States, Iowa City, Iowa, United States +1 more

Tafasitamab and Lenalidomide Followed by Tafasitamab and ICE As Salvage Therapy for Transplant Eligible Patients with Relapsed/ Refractory Large B-Cell Lymphoma

NCT ID: NCT05821088

This clinical trial is exploring a new treatment approach for patients with large B-cell lymphoma that has either returned after treatment (relapsed) or did not respond to previous therapies (refra...

Recruiting

Phase: PHASE2 Type: interventional Locations: Columbus, Ohio, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions